linkedin

IR Notice

Notice

2021 Closing Announcement of FY2021

 

Closing Announcement of FY2021

CONSOLEIDATED STATEMENTS OF FINANCIAL POSITION

As of December 31, 2021

(Unit : KRW)

Information on the subject, amount, and amount of the statement of financial position of the settlement announcement

Details of the statement of financial position of the settlement

Account Amount Account Amount
ASSETS LIABILITIES
1. CURRENT ASSETS 2,823,175,325,351 1. CURRENT LIABILITIES 1,107,294,649,465
Cash and cash equivalents 47,410,383,773 Trade and other current payables 399,030,093,590
Short-term financial instruments 450,000,000,000 Emission liability 725,692,500
Financial assets at fair value through profit or 850,039,876,800 Debentures and borrowings 159,855,000,000
Trade and other current receivables 366,330,684,127 Other current liabilities 364,409,220,047
Inventories 1,012,870,791,066 Contract liabilities 65,563,229,062
Other current financial assets 23,984,945,243 Lease liabilities 7,537,132,303
Other current assets 8,627,800,354 Current tax liabilities 110,174,301,963
Current contract assets 63,910,843,988
Ⅱ. NON-CURRENT LIABILITIES 1,871,613,996,718
Trade and other payables 9,152,703,103
Debentures and borrowings 1,114,683,996,094
Other non-current liabilities 29,335,889,118
Contract liabilities 220,058,599,452
Ⅱ. NON-CURRENT ASSETS 5,146,835,461,512 Deferred tax liabilities 487,711,642,843
Long-term financial instruments 189,491,294
Investments in associate and joint venture 2,661,309,486,003 TOTAL LIABILITIES 2,978,908,646,183
Property, pant and equipment 2,207,063,705,617
Intangible assets 32,171,618,395 EQUITY
Right-of-use assets 20,623,773,334 Share capital 165,412,500,000
Trade andother receivables 4,428,344,378 Share premium 2,487,313,082,024
Defined beneift asset 3,572,380,111 Accumulated other comprehensive loss (8,810,638,260)
Other non-current financial assets 26,919,379,491 Retained earnings 2,347,187,196,916
Other non-current assets 1,226,182,746
Contract assets 189,331,100,143 TOTAL EQUITY 4,991,102,140,680
TOTAL ASSETS 7,970,010,786,863 TOTAL LIABILITIES AND EQUITY 7,970,010,786,863

March 29, 2022

SAMSUNG BIOLOGICS CO., LTD

president & CEO John Rim

The financial statements present fairly, in all material respects, the financial position the Company as of December 31, 2021

Samil PricewaterhouseCoopers CEO Soonsoo Yoon